SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Metagenomi, Inc. – MGX
NEW YORK, Oct. 17, 2024 /PRNewswire/ — Pomerantz LLP announces that a class action lawsuit has been filed against Metagenomi, Inc. (“Metagenomi” or the “Company”) (NASDAQ: MGX). Such investors are advised to contact Danielle Peyton at [email protected] or 646-58
SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Metagenomi, Inc. – MGX
NEW YORK, Oct. 17, 2024 /PRNewswire/ — Pomerantz LLP announces that a class action lawsuit has been filed against Metagenomi, Inc. (“Metagenomi” or the “Company”) (NASDAQ: MGX). Such investors are advised to contact Danielle Peyton at [email protected] or 646-58
AusperBio to Present Ongoing AHB-137 Clinical Data in Late-Breaking Oral Presentation at AASLD 2024
SAN FRANCISCO, Oct. 17, 2024 /PRNewswire/ — AusperBio Therapeutic, Inc. and Ausper Biopharma Co., Ltd. (together AusperBio), a clinical-stage biotechnology company, today announced that new clinical data from its lead candidate AHB-137, an antisense oligonucleotide (ASO) therapeutic, will be f
AusperBio to Present Ongoing AHB-137 Clinical Data in Late-Breaking Oral Presentation at AASLD 2024
SAN FRANCISCO, Oct. 17, 2024 /PRNewswire/ — AusperBio Therapeutic, Inc. and Ausper Biopharma Co., Ltd. (together AusperBio), a clinical-stage biotechnology company, today announced that new clinical data from its lead candidate AHB-137, an antisense oligonucleotide (ASO) therapeutic, will be f
AusperBio to Present Ongoing AHB-137 Clinical Data in Late-Breaking Oral Presentation at AASLD 2024
SAN FRANCISCO, Oct. 17, 2024 /PRNewswire/ — AusperBio Therapeutic, Inc. and Ausper Biopharma Co., Ltd. (together AusperBio), a clinical-stage biotechnology company, today announced that new clinical data from its lead candidate AHB-137, an antisense oligonucleotide (ASO) therapeutic, will be f
AusperBio to Present Ongoing AHB-137 Clinical Data in Late-Breaking Oral Presentation at AASLD 2024
SAN FRANCISCO, Oct. 17, 2024 /PRNewswire/ — AusperBio Therapeutic, Inc. and Ausper Biopharma Co., Ltd. (together AusperBio), a clinical-stage biotechnology company, today announced that new clinical data from its lead candidate AHB-137, an antisense oligonucleotide (ASO) therapeutic, will be f
Dr. Andrew Kelly Scholarship for Future Doctors: Igniting Passion and Rewarding Dedication in Aspiring Medical Professionals
ADVANCE, N.C., Oct. 17, 2024 /PRNewswire/ — Dr. Andrew Kelly, a distinguished Implantologist and Dental Implant Specialist with over 30 years of experience, is proud to announce the Dr. Andrew Kelly Scholarship for Future Doctors. This prestigious scholarship program is designed to support an
Dr. Andrew Kelly Scholarship for Future Doctors: Igniting Passion and Rewarding Dedication in Aspiring Medical Professionals
ADVANCE, N.C., Oct. 17, 2024 /PRNewswire/ — Dr. Andrew Kelly, a distinguished Implantologist and Dental Implant Specialist with over 30 years of experience, is proud to announce the Dr. Andrew Kelly Scholarship for Future Doctors. This prestigious scholarship program is designed to support an
Dr. Andrew Kelly Scholarship for Future Doctors: Igniting Passion and Rewarding Dedication in Aspiring Medical Professionals
ADVANCE, N.C., Oct. 17, 2024 /PRNewswire/ — Dr. Andrew Kelly, a distinguished Implantologist and Dental Implant Specialist with over 30 years of experience, is proud to announce the Dr. Andrew Kelly Scholarship for Future Doctors. This prestigious scholarship program is designed to support an
Dr. Andrew Kelly Scholarship for Future Doctors: Igniting Passion and Rewarding Dedication in Aspiring Medical Professionals
ADVANCE, N.C., Oct. 17, 2024 /PRNewswire/ — Dr. Andrew Kelly, a distinguished Implantologist and Dental Implant Specialist with over 30 years of experience, is proud to announce the Dr. Andrew Kelly Scholarship for Future Doctors. This prestigious scholarship program is designed to support an
